Currently, the Phase III trials for CoronaVac have been approved in Brazil, Indonesia, Turkey, and Chile. Meanwhile, the Brazilian city of Sao Paulo has started funding a facility to produce 100 million doses a year of China’s Sinovac vaccine against COVID-19, which is expected to be ready by September 2021.
